Synaptic Medical, a China-based cardiac electrophysiology company, has raised nearly $60m in its series G round from a consortium including technology company Susquehanna International Group (SIG).
Huagai Capital led the round, which also included Bio Venture Capital as reported by 36Kr.
Haoyue Capital is financial adviser.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
